Login
Toggle navigation
Videos
Categories
Trending
Capital- Building Engaged Crypto Communities|Niv Dror,Managing Partner,Shrug Capital
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Niv Dror is a Managing Partner at Shrug Capital.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Understanding 409A Valuations: Key Insights for Employee Stock Compensation | Mark Dempster, Co-Founder, Founders Circle Capital.
00:00:00
OptiBiotix Health delighted to launch range in India through Apollo - Stephen Patrick O'Hara CEO / Founder, OptiBiotix Health
00:10:00
Michael Underhill on Energy Independence and Real Asset Investing Amid Geopolitical Shifts
00:10:00
Pear: Nurturing Innovation Through Early-Stage Investment|Pejman Nozad,partner,Pear VC
00:10:00
Alexander Geis Discusses Opportunities and Challenges in Mexico's Cargo Transport Industry | Alexander Geis, CEO , SAF-HOLLAND SE.
00:10:00
Rumble CEO Chris Pavlovski joins 'Mornings with Maria' to discuss his company's perspective on the matter.
00:10:00
Gold Price Dynamics: Factors Influencing Future Trends
00:10:00
The Marathon of Investing: Parallels Between Running and Financial Planning | B.Gopkumar, CEO , Axis Mutual Fund.
00:10:00
AEMX Exploration's Pom Project: Advancing High-Grade Gold Discovery with New Funding
00:10:00
Decoding Finance: Wisdom Tree's CEO on ETFs and Blockchain Innovation | Jonathan Steinberg, CEO ,WisdomTree Investments.
00:10:00
Macro Risks: Insights Live on Finding Relative Value with Wayne Dahl, Madelaine Jones, and David Rosenberg
00:10:00
AIL Mining at Mine Expo: Innovative Solutions and Networking